Ginkgo Bioworks Holdings, Inc. (DNA) Stock Price

DNAStock

$7.54−45.98%52W

Market Cap$507.75M

P/E—

PEG Ratio—

Div yield—

Beta1.90

DNA Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-35.49%

Price vs S&P 500 (4W)-15.00%

VGM Score46.39

Book Value / Share (Quarterly)$7.19

P/TBV (Annual)1.11x

Revenue Growth (3Y)-29.11%

Cash Flow / Share (Quarterly)$-2.73

Price vs S&P 500 (YTD)-30.37%

Gross Margin (TTM)73.09%

Net Profit Margin (TTM)-215.41%

EPS (TTM)$-5.35

10-Day Avg Trading Volume1.32M

EPS Excl Extra (TTM)$-5.35

Revenue Growth (5Y)17.28%

EPS (Annual)$-5.64

ROI (Annual)-61.49%

Gross Margin (Annual)72.39%

Net Profit Margin (5Y Avg)-360.73%

Cash / Share (Quarterly)$6.06

Revenue Growth QoQ (YoY)-59.70%

ROA (Last FY)-27.93%

Revenue Growth TTM (YoY)-40.48%

EBITD / Share (TTM)$-4.50

ROE (5Y Avg)-92.41%

Operating Margin (TTM)-220.92%

Cash Flow / Share (Annual)$-3.07

P/B Ratio1.10x

P/B Ratio (Quarterly)0.82x

Net Income / Employee (Annual)$-644,900

EV / Revenue (TTM)2.43x

Net Interest Coverage (TTM)-2640.83x

ROA (TTM)-26.63%

EPS Incl Extra (Annual)$-5.64

Current Ratio (Annual)4.92x

Quick Ratio (Quarterly)5.03x

3-Month Avg Trading Volume1.21M

52-Week Price Return-45.98%

Revenue / Employee (TTM)$291,400

Tangible BV / Share (Quarterly)$6.39

P/S Ratio (Annual)2.87x

Asset Turnover (Annual)0.15x

52-Week High$17.58

Operating Margin (5Y Avg)-370.56%

EPS Excl Extra (Annual)$-5.64

CapEx CAGR (5Y)-33.24%

26-Week Price Return-24.25%

Quick Ratio (Annual)4.73x

13-Week Price Return-16.09%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)5.15x

Enterprise Value$343.68M

Revenue / Share Growth (5Y)137.15%

Asset Turnover (TTM)0.12x

Revenue / Employee (Annual)$350,800

Inventory Turnover (Annual)24.29x

Pretax Margin (Annual)-184.30%

Cash / Share (Annual)$7.26

3-Month Return Std Dev85.69%

Gross Margin (5Y Avg)69.44%

Net Income / Employee (TTM)$-627,600

ROE (Last FY)-61.50%

Net Interest Coverage (Annual)-16.40x

EPS Basic Excl Extra (Annual)$-5.64

Receivables Turnover (TTM)5.96x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-5.35

Receivables Turnover (Annual)7.29x

ROI (TTM)-57.31%

P/S Ratio (TTM)3.45x

Pretax Margin (5Y Avg)-362.08%

Revenue / Share (Annual)$3.07

Tangible BV / Share (Annual)$7.76

Price vs S&P 500 (52W)-64.29%

Year-to-Date Return-18.41%

5-Day Price Return3.83%

EPS Normalized (Annual)$-5.64

ROA (5Y Avg)-58.50%

Net Profit Margin (Annual)-183.81%

Month-to-Date Return-16.19%

Cash Flow / Share (TTM)$-0.41

EBITD / Share (Annual)$-4.92

Operating Margin (Annual)-194.89%

ROI (5Y Avg)-92.03%

EPS Basic Excl Extra (TTM)$-5.35

P/TBV (Quarterly)0.92x

P/B Ratio (Annual)0.99x

Inventory Turnover (TTM)24.30x

Pretax Margin (TTM)-211.50%

Book Value / Share (Annual)$8.74

Price vs S&P 500 (13W)-18.88%

Beta1.90x

Revenue / Share (TTM)$2.37

ROE (TTM)-57.31%

52-Week Low$5.37

vGradeB

gGradeD

mGradeD

vgmGradeC

DNA Earnings Surprise History

Q2 25-1.10est. -1.57

Q3 25-1.45est. -1.24

Q4 25-0.77est. -1.11

Q1 26-1.39est. -1.34

Q2 26-0.73est. -0.70

DNA Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

2.09

2.20

Industry Peers — Biological Products(183)

Symbol	Value Score	Growth Score	Momentum Score	Price
DNAGinkgo Bioworks Holdings, Inc.	B	D	D	$7.54
AMGNAmgen Inc	C	C	B	$442.24
GILDGilead Sciences Inc	C	B	B	$148.77
MRNAModerna, Inc. Common Stock	D	C	A	$158.83
ARGXargenx SE American Depositary Shares	D	A	B	$1019.49
RVMDRevolution Medicines, Inc. Common Stock	F	—	A	$211.38
BIIBBiogen Inc. Common Stock	C	D	B	$220.77
BNTXBioNTech SE American Depositary Share	C	C	B	$114.05
NBIXNeurocrine Biosciences Inc	C	B	C	$153.37
EXELExelixis Inc	C	B	B	$56.72
HALOHalozyme Therapeutics, Inc.	C	B	A	$109.32
TECHBio-Techne Corp.	D	C	B	$72.33
KRYSKrystal Biotech, Inc. Common Stock	D	B	B	$356.19
KYMRKymera Therapeutics, Inc. Common Stock	D	B	B	$126.64
RGENRepligen Corp	D	C	A	$181.69
APGEApogee Therapeutics, Inc. Common Stock	—	—	A	$134.85
TWSTTwist Bioscience Corporation Common Stock	D	B	A	$151.42
PCVXVaxcyte, Inc. Common Stock	—	—	B	$61.09
QGENQIAGEN N.V.	C	C	C	$43.65
IMVTImmunovant, Inc. Common Stock	—	—	B	$43.50
IBRXImmunityBio, Inc. Common Stock	F	A	C	$8.19
SRRKScholar Rock Holding Corporation Common Stock	F	—	B	$58.25
CGONCG Oncology, Inc. Common stock	F	A	A	$78.95
CRSPCRISPR Therapeutics AG	D	B	B	$60.90
RLAYRelay Therapeutics, Inc. Common Stock	F	D	A	$20.57
ADPTAdaptive Biotechnologies Corporation Common Stock	D	B	A	$26.25
DNLIDenali Therapeutics Inc. Common Stock	F	—	B	$24.93
IOVAIovance Biotherapeutics, Inc. Common Stock	C	B	A	$8.44
BEAMBeam Therapeutics Inc. Common Stock	C	B	B	$31.03
TARSTarsus Pharmaceuticals, Inc. Common Stock	D	A	B	$71.45
BCRXBioCryst Pharmaceuticals Inc	B	A	B	$9.83
KODKodiak Sciences Inc Common Stock	—	—	B	$39.46
COAGHemab Therapeutics Holdings, Inc. Common Stock	—	—	B	$49.65
MESOMesoblast Limited American Depositary Shares	D	B	C	$17.19
VCELVericel Corporation	D	B	C	$43.22
ADMAADMA Biologics, Inc.	C	C	C	$9.72
TSHATaysha Gene Therapies, Inc. Common Stock	F	B	B	$6.20
IMCRImmunocore Holdings plc American Depositary Shares	D	B	B	$37.40
RXRXRecursion Pharmaceuticals, Inc. Class A Common Stock	D	C	C	$3.56
VIRVir Biotechnology, Inc. Common Stock	B	B	B	$10.71
INBXInhibrx Biosciences, Inc. Common Stock	D	C	B	$122.72
ALVOAlvotech Ordinary Shares	C	D	B	$5.05
MAZEMaze Therapeutics, Inc. Common Stock	—	—	B	$30.42
NVAXNovavax Inc	B	D	C	$9.44
REPLReplimune Group, Inc.	—	—	A	$15.80
SLBTSL Science Holding Limited Ordinary Shares	—	—	F	$2.64
MGTXMeiraGTx Holdings plc Ordinary Shares	D	C	A	$14.92
VORVor Biopharma Inc. Common Stock	—	—	B	$24.01
CGEMCullinan Therapeutics, Inc. Common Stock	—	—	A	$22.95
IMTXImmatics N.V. Ordinary Shares	C	D	C	$9.24
ODTXOdyssey Therapeutics, Inc. Common Stock	—	C	A	$26.23

About Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks provides a cell programming platform offering biological R&D services and end-to-end solutions across pharmaceuticals, agriculture, food, and industrial markets. The company operates two segments: Cell Engineering, which generates the majority of revenue through customer biological research and development, and Biosecurity, which provides biological threat identification, monitoring, and mitigation services for government and commercial customers.